A
Akari Therapeutics (AKTX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Akari Therapeutics (AKTX)
Akari Therapeutics, Plc is a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases. The Company's lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activati... Read more
- USD1.16
- USD1.18
- USD1.16
- USD4.40
- -8.00%
- --
- 8.22k
- 21.58k
- 37M
- 0.85
- -55.90%
Stock News
yesterday
Meta’s stock hits a record high as Mark Zuckerberg goes on an AI hiring spree
MarketWatch
yesterday
25-year-old skipped college—now her company brings in more than $1 million a week on Whatnot
CNBC
yesterday
QXO turns attention elsewhere as Home Depot nabs GMS - source
Yahoo
yesterday
Market lessons from the first half of 2025 — and, stocks that look good going forward
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
